Closed call · historical reference
Expected Impact:The starting point in the project should be a preliminary technology or protocol of an RNA-based therapy for complex or rare genetic diseases with unmet medical needs that demonstrates, in a lab or preclinical context, the essential features that underpin the disruptive nature of th…
Topics
Partner types
business, research_center, university